In a post-COVID-19 era, healthcare executives are preparing to reinvent their businesses.
Health care payors
As variants of the COVID-19 virus emerge, genomic sequencing could help boost the public health response and provide the impetus to create value for future crises.
The payer CMO has moved from a physician executive to strategic business partner. Organizations that embrace this expanded and diversified role for the CMO can create sustained competitive advantage and unlock significant value for the enterprise and its stakeholders.